Stay updated with breaking news from Ecdna. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CareDx (NASDAQ:CDNA – Get Free Report) and BioNexus Gene Lab (NASDAQ:BGLC – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, earnings, institutional ownership, risk, valuation, profitability and analyst recommendations. Valuation and Earnings This table compares CareDx […]
Stephens reaffirmed their overweight rating on shares of CareDx (NASDAQ:CDNA – Free Report) in a report issued on Wednesday morning, Benzinga reports. The brokerage currently has a $15.00 target price on the stock. CareDx Stock Up 3.0 % Shares of CDNA stock opened at $8.31 on Wednesday. The firm has a market cap of $430.29 […]
CareDx, Inc (NASDAQ:CDNA – Free Report) – Equities researchers at HC Wainwright lifted their FY2023 EPS estimates for shares of CareDx in a research note issued on Monday, January 29th. HC Wainwright analyst Y. Chen now forecasts that the company will earn ($1.76) per share for the year, up from their prior forecast of ($1.79). […]
By Chris Wack An unanimous verdict in favor of Natera in its patent infringement case against CareDx has been reached by a jury in the U.S. District Court...
By Chris Wack CareDX shares were down 7% at $8.43 after a jury in the U.S. District Court for the District of Delaware reached a unanimous verdict in favor...